Skip to main content
Figure 4 | Genome Medicine

Figure 4

From: MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32

Figure 4

Recurrence risk prediction in relevant homogeneous patient subsets and using miRNA gene targets. (A) Kaplan-Meier recurrence analysis with the five miRNA profile in the non-metastatic (only) subset of the cohort. (B) Kaplan-Meier recurrence analysis with the five miRNA profile in the subset of patients that received MAP (only). (C) Kaplan-Meier recurrence analysis using a subset of gene targets of prognostic miRNAs.

Back to article page